mynth
12/2019

SOFTWAY MEDICAL acquired by FIVE ARROWS

FRANCE Software / Industry-Specific Software / Healthcare EV 100M - 350M EUR

Context

Securing a specialized digital health platform that generates in annual turnover, Five Arrows Principal Investments executed the buyout of Softway Medical in December 2019. This transaction officially transfers ownership from the target's former institutional backer, the private equity firm Naxicap Partners. Structured as a secondary leveraged buyout, the definitive agreement aligns with the acquiring sponsor's mandate to invest in mature technology assets. The strategic rationale articulated around the deal focuses on capitalizing on the accelerating digitization of medical infrastructure, a sub-sector attracting sustained investor interest due to strict regulatory compliance and the demand for workflow automation. By backing the software provider, the financial sponsor instantly captures a dominant market position within the French healthcare ecosystem. Throughout the transaction process, the buy-side execution was managed by Arma Partners, which acted as the exclusive financial advisor to the acquiring private equity fund.

-> Deep-dive in TMT (Tech, Media, Telecom) market trends

Target

Founded in 1999, Softway Medical specializes in cloud-native healthcare software solutions and designs comprehensive digital infrastructures aimed at optimizing clinical and administrative workflows across various European healthcare facilities. Located in Fuveau, within the Bouches-du-Rhône department, the technology provider maintains a massive operational footprint anchored by a deployment across 1,300 hospitals and clinics. This extensive penetration translates to a commanding 40 percent market share in its domestic institutional segment. Furthermore, the proprietary software ecosystem serves an established network comprising 1,300 specialized radiology centers, 700 multidisciplinary health centers, and 400 medical laboratories. To sustain the continuous development of its technological portfolio, the organization relies on a workforce exceeding 1,200 dedicated professionals. Under the operational leadership of Chief Executive Officer Guillaume Pascal, the software publisher executes a structured expansion strategy, notably conceptualized through its internal eNov development plan. This growth trajectory is historically supported by a vigorous external integration roadmap, characterized by the successful assimilation of ten strategic acquisitions, including the Belgian entity SBIM and epidemiology data firm EpiConcept. The enterprise also maintains active distribution channels in Canada. The core engineering focus remains firmly centered on translating complex healthcare data into actionable, secure digital environments.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year
Rev
EBITDA
EBIT
2020
2019

Other operations with SOFTWAY MEDICAL

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
DateAcquirerTargetCountrySector
05/2025BAIN CAPITALSOFTWAY MEDICALFRANCEHealthcare

REFERENCES

Valuation range: EV 100M - 350M EUR

Revenue range: 50M - 100M EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of SOFTWAY MEDICAL by FIVE ARROWS are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Target: softway medical

Acquirer: five arrows